PMID- 24218453 OWN - NLM STAT- MEDLINE DCOM- 20140218 LR - 20231213 IS - 1550-6606 (Electronic) IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 191 IP - 12 DP - 2013 Dec 15 TI - Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism. PG - 5875-84 LID - 10.4049/jimmunol.1301693 [doi] AB - Foxp3(+) T regulatory cells (Tregs) are critically important for the maintenance of immunological tolerance, immune homeostasis, and prevention of autoimmunity. Dendritic cells (DCs) are one of the major targets of Treg-mediated suppression. Some studies have suggested that Treg-mediated suppression of DC function is mediated by the interaction of CTLA-4 on Tregs with CD80/CD86 on the DCs resulting in downregulation of CD80/CD86 expression and a decrease in costimulation. We have re-examined the effects of Tregs on mouse DC function in a model in which Ag-specific, induced Tregs (iTregs) are cocultured with DCs in the absence of T effector cells. iTreg-treated DCs are markedly defective in their capacity to activate naive T cells. iTregs from CTLA-4-deficient mice failed to induce downregulation of CD80/CD86, but DCs treated with CTLA-4-deficient iTregs still exhibited impaired capacity to activate naive T cells. The iTreg-induced defect in DC function could be completely reversed by anti-IL-10, and IL-10-deficient iTregs failed to downregulate DC function. iTreg-treated DCs expressed high levels of MARCH1, an E3 ubiquitin ligase, recently found to degrade CD86 and MHC class II on the DCs and expressed lower levels of CD83, a molecule involved in neutralizing the function of MARCH1. Both the enhanced expression of MARCH1 and the decreased expression of CD83 were mediated by IL-10 produced by the iTregs. Taken together, these studies demonstrate that a major suppressive mechanism of DC function by iTregs is secondary to the effects of IL-10 on MARCH1 and CD83 expression. FAU - Chattopadhyay, Gouri AU - Chattopadhyay G AD - Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892. FAU - Shevach, Ethan M AU - Shevach EM LA - eng GR - Z01 AI000224-27/Intramural NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Intramural DEP - 20131111 PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Antigens, CD) RN - 0 (B7-1 Antigen) RN - 0 (B7-2 Antigen) RN - 0 (CTLA-4 Antigen) RN - 0 (Cd86 protein, mouse) RN - 0 (Ctla4 protein, mouse) RN - 0 (DNA-Binding Proteins) RN - 0 (Epitopes, T-Lymphocyte) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (IL10 protein, mouse) RN - 0 (Immunoglobulins) RN - 0 (Membrane Glycoproteins) RN - 0 (RNA, Messenger) RN - 0 (Rag2 protein, mouse) RN - 130068-27-8 (Interleukin-10) RN - EC 2.3.2.27 (MARCH1 protein, mouse) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) SB - IM MH - Animals MH - Antigen Presentation MH - Antigens, CD/biosynthesis/genetics/*physiology MH - B7-1 Antigen/biosynthesis/genetics MH - B7-2 Antigen/biosynthesis/genetics MH - CD4-Positive T-Lymphocytes/immunology MH - CTLA-4 Antigen/deficiency/physiology MH - Cell Separation MH - Cells, Cultured MH - Coculture Techniques MH - DNA-Binding Proteins/deficiency MH - Dendritic Cells/*immunology MH - Epitopes, T-Lymphocyte/*immunology MH - Flow Cytometry MH - Gene Expression Regulation/*immunology MH - Histocompatibility Antigens Class II/immunology MH - Immune Tolerance/*immunology MH - Immunoglobulins/biosynthesis/genetics/*physiology MH - Interleukin-10/antagonists & inhibitors/deficiency/metabolism/*physiology MH - Lymphocyte Activation MH - Membrane Glycoproteins/biosynthesis/genetics/*physiology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Mice, Transgenic MH - RNA, Messenger/biosynthesis MH - *T-Cell Antigen Receptor Specificity MH - T-Lymphocytes, Regulatory/*immunology/metabolism MH - Ubiquitin-Protein Ligases/biosynthesis/genetics/*physiology MH - CD83 Antigen PMC - PMC3858537 MID - NIHMS529610 EDAT- 2013/11/13 06:00 MHDA- 2014/02/19 06:00 PMCR- 2014/12/15 CRDT- 2013/11/13 06:00 PHST- 2013/11/13 06:00 [entrez] PHST- 2013/11/13 06:00 [pubmed] PHST- 2014/02/19 06:00 [medline] PHST- 2014/12/15 00:00 [pmc-release] AID - jimmunol.1301693 [pii] AID - 10.4049/jimmunol.1301693 [doi] PST - ppublish SO - J Immunol. 2013 Dec 15;191(12):5875-84. doi: 10.4049/jimmunol.1301693. Epub 2013 Nov 11.